QA²I delivers AI tools for the world's most regulated manufacturers, producing audit-ready compliance documentation in a fraction of the time and cost of manual work.
EU GMP-regulated pharmaceutical manufacturers must produce a continuous stream of quality documents: supplier audits, product quality reviews, regulatory submissions, and more. Each requires days of manual preparation by senior QA professionals.
Existing solutions store and track documents but do not generate them. The work remains entirely manual, consuming expensive expert capacity that should be focused on judgment-intensive decisions.
QA²I combines Quality Assurance and Artificial Intelligence, with the "²" symbolizing QA amplified by AI.
We started QA²I with a single belief: that the most important documents in pharmaceutical manufacturing, the ones that prove product safety and process control to regulators, should not be the ones most prone to human error and delay.
Our ambition isn't to remove humans from compliance. It is to give the experts the most capable assistants. The AI handles what's repetitive: reading, cross-referencing, drafting. The expert handles what matters: verifying, judging, deciding. AI that reasons across data, prepares documents with domain fluency, and defers to human judgment at every gate. Less time assembling, more time deciding.

Ivan Lugovoi
Co-Founder & CEO
Brings over a decade of pharma leadership as CEO of a Swissmedic-approved distributor and Managing Director of an anticancer API producer approved by the US FDA, EMA, and PMDA.

Max Guba
Co-Founder & COO
Combines a background in AI, business, and regulated industries, supported by research on AI implementation in pharma compliance. Focuses on business development and daily operations at QA²I.

Alexandre Lugovoi
Co-Founder & AI Engineer
Grounded in computer science and machine learning, with research experience at ETH Zurich in neural decoding and data engineering. Architects the systems that make AI outputs auditable and deployable in regulated environments.
QA²I uses AI agents to automate preparation of compliant, traceable pharmaceutical quality documents. Specialized agents handle document ingestion, cross-document consistency checks, regulatory criteria matching, and structured output generation within a validated pipeline.
Every output traces back to source documents, satisfying EU GMP Annex 11 and ALCOA+ requirements. Human experts review and approve all outputs. The result is audit-ready documentation produced in a fraction of the time and cost of manual preparation.
See how QA²I's AI pipeline can turn weeks of manual document work into days, with full audit transparency.
We use cookies to understand how visitors use this site. We only turn on analytics if you accept. Privacy Policy